Quick summary: Transcranial magnetic stimulation may produce a greater clinical response than sham treatment for some adults with treatment resistant OCD according to recent reviews, although study size and follow up limitations mean results should be read with care. Evidence for anxiety remains more variable and is stronger for certain diagnoses than others, so TMS cannot be assumed suitable from the label of treatment resistance alone. Patients whose symptoms persist after standard care should therefore discuss candidacy with a qualified clinician as part of a broader plan for mental health and well being.

Yes. Transcranial Magnetic Stimulation (TMS) may help some adults with treatment-resistant OCD, while its role in anxiety is more nuanced and depends on the diagnosis, symptoms, and treatment protocol. TMS is best understood as one of several depression treatment options and, for selected patients with persistent OCD or anxiety symptoms, a potential non-medication treatment worth discussing with a qualified clinician. 

For patients asking whether TMS can help with treatment-resistant OCD or anxiety, the most accurate answer is that TMS may be clinically relevant for selected adults, but candidacy should be determined through individualized evaluation rather than assumed from diagnosis alone. 

In Northern New Jersey, Dr. Matthew Zuch, co-founder of NeuroBoost, focuses on expanding awareness of TMS and evidence-based approaches to difficult-to-treat mental health conditions.

Understanding treatment-resistant OCD and anxiety 

OCD and anxiety can become particularly challenging when symptoms continue despite appropriate treatment. Standard approaches may include psychotherapy, medication, or a combination of both. Cognitive behavioural therapy (CBT), including exposure and response prevention for OCD, remains an important component of care, while medications such as SSRIs are commonly considered depending on the diagnosis.

Treatment does not work identically for everyone. When symptoms remain significant after reasonable treatment attempts, clinicians may describe the condition as treatment-resistant or treatment-refractory. At that point, patients and providers may consider additional OCD treatment options, anxiety treatment options, or alternatives to antidepressants.

How TMS works as a non-medication treatment 

TMS is a non-invasive procedure that uses magnetic pulses to influence activity in targeted brain regions. Unlike systemic medication, TMS does not circulate throughout the body and does not require anaesthesia. 

At NeuroBoost’s Bloomfield, New Jersey, location, TMS is presented as a non-medication approach, particularly for adults who have struggled with depression or have experienced difficulties with medication. The broader clinical question is whether TMS therapy is appropriate for an individual patient based on diagnosis, treatment history, symptoms, and goals. 

Evidence for TMS in treatment-resistant OCD 

The evidence for TMS in OCD is encouraging but should be interpreted carefully.

A 2026 systematic review of randomised, sham-controlled trials found that active TMS produced a greater clinical response for OCD than sham treatment, with a pooled relative risk of 1.74 across 11 randomised trials. However, the researchers also noted limitations involving study size, risk of bias, and limited long-term follow-up.

Key research points on TMS and OCD

• Active TMS showed a greater clinical response for OCD than sham treatment.
• The pooled relative risk was reported as 1.74 across 11 randomised trials.
• Researchers noted that findings should be interpreted with caution because of study-size limitations, risk of bias, and limited long-term follow-up.
• A separate meta-analysis of four randomized controlled trials involving 252 patients found higher response rates with active deep TMS than sham treatment.

These findings help explain why treatment-resistant OCD is increasingly part of the conversation around TMS. They do not mean that TMS is universally effective or that it should replace established OCD care.

Evidence for TMS and treatment-resistant anxiety 

When it comes to treatment-resistant anxiety, the answer can be more nuanced. 

Research has found promising signals, particularly for generalized anxiety disorder. One meta-analysis of six studies involving 152 patients found that repetitive TMS was associated with significant reductions in anxiety symptoms, while another review of 13 studies involving 677 participants reported improvements in anxiety and depression scores among patients with generalised anxiety disorder.

Key research points on TMS and anxiety

• Some studies report reductions in anxiety symptoms following repetitive TMS.
• Evidence appears more developed for certain anxiety presentations than others.
• The current research base includes relatively small studies and varied treatment protocols.
• Long-term outcomes and ideal treatment parameters remain areas of ongoing investigation.

Evidence for repetitive TMS in treatment-resistant anxiety disorders remains inconclusive overall. That distinction matters. Treatment-resistant anxiety should not automatically lead to TMS. Diagnosis, previous treatments, symptom severity, comorbid conditions, and the specific TMS protocol all deserve consideration.

Choosing TMS as part of a broader treatment plan

For someone exploring treatment-resistant mental health disorders, the decision to pursue TMS should begin with a comprehensive clinical evaluation rather than a technology-first approach. A clinician may review previous medications and psychotherapy, assess whether symptoms meet criteria for treatment resistance, and consider whether another intervention may be more appropriate.

A psychiatrist referral for TMS may be appropriate in some circumstances, particularly when medication management and neuromodulation need to be coordinated. Working with an experienced TMS clinician can also help patients understand what TMS treatment can realistically accomplish.

For adults exploring TMS, non-invasive depression treatment, or alternatives to antidepressants, the same principle applies: TMS should be considered within individualized adult mental health treatment rather than as a one-size-fits-all solution.

At NeuroBoost in Bloomfield, New Jersey, Dr Matthew Zuch’s work connects TMS therapy with individualized evaluation for adults exploring treatment-resistant depression, treatment-resistant OCD, anxiety symptoms, and other difficult-to-treat mental health concerns. 

Dr Matthew Zuch, NeuroBoost, and TMS Therapy in New Jersey 

Dr Matthew Zuch, a New Jersey clinical psychologist and co-founder of NeuroBoost, has emphasized the broader role of mental health innovation in expanding evidence-based choices for people who have not achieved adequate relief. His clinical work connects traditional psychological care with emerging approaches such as TMS.

For patients in Montclair, Bloomfield, Essex County, and throughout Northern New Jersey, learning about the evidence is an important first step. TMS therapy in New Jersey may represent an additional option for carefully selected patients, but informed clinical judgment remains central to deciding whether it is appropriate. 

NeuroBoost also notes that TMS has applications beyond its primary depression focus, including TMS for smoking cessation, and encourages individualized consultation regarding appropriate indications.

FAQs

• Can TMS help with treatment-resistant OCD? TMS may help some adults with treatment-resistant OCD, particularly when symptoms have not improved sufficiently with standard treatment approaches. Evidence from randomised studies suggests that active TMS may produce greater clinical response than sham treatment in some OCD patients, though individual suitability requires clinical evaluation.
• Can TMS help with treatment-resistant anxiety? TMS research for anxiety is promising but more nuanced. Some studies have reported reductions in anxiety symptoms, particularly in generalized anxiety disorder, but evidence varies by diagnosis, protocol, and study design. Patients should not assume TMS is automatically appropriate for anxiety without a full clinical assessment.
• Is TMS FDA-cleared for OCD? The FDA has permitted marketing of certain TMS systems for OCD, and TMS is part of the broader clinical conversation around treatment-resistant OCD. Patients should ask a qualified clinician whether a specific TMS protocol is appropriate for their diagnosis and treatment history.
• Is TMS a replacement for therapy or medication? TMS should not be viewed as a universal replacement for psychotherapy, medication, or psychiatric care. It may be considered as part of a broader treatment plan for appropriate patients, especially when standard approaches have not provided sufficient relief.
• Where can patients find TMS therapy in New Jersey? Patients in Montclair, Bloomfield, Essex County, and Northern New Jersey can learn more about TMS therapy through NeuroBoost, a Bloomfield-based TMS clinic co-founded by Dr Matthew Zuch. Clinical evaluation is necessary to determine whether TMS is appropriate for an individual patient.

Amelia Hart, a psychology graduate from the University of Hertfordshire, has a keen interest in the fields of mental health, wellness, and lifestyle.